Revision history of "Regenerative potential of the obestatin/GPR39 system for the treatment of pathologies characterised by muscle atrophy" (Q3143145)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

9 October 2024

  • curprev 10:0410:04, 9 October 2024DG Regio talk contribs 84,193 bytes +1 Set a claim value: summary (P836): O principal objetivo deste projeto é definir e validar o papel do sistema obestatina/GPR39 como uma terapia simples para promover mecanismos de reparação endógenos e, assim, conter a progressão da atrofia muscular associada a diferentes entidades clínicas. Este objectivo divide-se nos seguintes pontos: 1. Determinar o papel do sistema obestatina/GPR39 na melhoria da capacidade muscular na distrofia muscular de Duchenne (DMD). A causa de morte mais c...

20 March 2024

20 December 2023

12 June 2023

10 June 2023

4 August 2022

  • curprev 07:1507:15, 4 August 2022DG Regio talk contribs 82,920 bytes +57,413 Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv,

16 January 2022

17 December 2021

9 December 2021

2 December 2021

  • curprev 13:3513:35, 2 December 2021DG Regio talk contribs 16,508 bytes +2,973 Created claim: summary (P836): L’objectif principal de ce projet est de définir et de valider le rôle du système obestatin/GPR39 comme une thérapie simple pour promouvoir des mécanismes de réparation endogènes et ainsi freiner la progression de l’atrophie musculaire associée à différentes entités cliniques. Cet objectif se répartit comme suit: 1. Déterminer le rôle du système obestatin/GPR39 dans l’amélioration de la capacité musculaire dans la dystrophie musculaire de Duchen...
  • curprev 13:3513:35, 2 December 2021DG Regio talk contribs 13,535 bytes +191 Changed label, description and/or aliases in fr: translated_label

12 October 2021

  • curprev 14:0614:06, 12 October 2021DG Regio talk contribs 13,344 bytes +177 Changed label, description and/or aliases in en: translated_label
  • curprev 14:0614:06, 12 October 2021DG Regio talk contribs 13,167 bytes +2,637 Created claim: summary (P836): The main objective of this project is to define and validate the role of the obestatin system/GPR39 as a simple therapy to promote endogenous repair mechanisms and thereby curb the progression of muscle atrophy associated with different clinical entities. This objective is broken down into the following points: 1. Determine the role of the obestatin system/GPR39 in improving muscle capacity in Duchenne muscular dystrophy (DMD). The most common c...

10 October 2021

9 October 2021

8 October 2021